Feasibility of esophageal endoscopic submucosal dissection after radiofrequency ablation treatment in patients with Barrett's esophagus Journal Article


Authors: Koseki, M.; Nishimura, M.; Nammour, T.; Nagao, S.; Schattner, M. A.
Article Title: Feasibility of esophageal endoscopic submucosal dissection after radiofrequency ablation treatment in patients with Barrett's esophagus
Abstract: Background and Aims: Radiofrequency ablation (RFA) is a well-established treatment for Barrett's esophagus (BE) in the United States. Similarly, endoscopic submucosal dissection (ESD) has been widely performed for early esophageal carcinoma. However, conducting ESD after RFA can be technically challenging. The aim of this study was to assess the feasibility and safety of ESD in patients with prior RFA. Methods: This study was a single-center retrospective analysis of patients who underwent esophageal ESD after undergoing prior RFA treatment for BE. Results: Of 44 esophageal ESD cases, 7 underwent prior RFA. In those 7 cases, the en bloc resection rate was 100%, and the R0 resection rate was 86%. No acute or delayed adverse events or rehospitalizations occurred in any patient. Conclusions: ESD may be a feasible and safe option for patients with a history of RFA. It could be considered for esophageal neoplasms in patients previously treated with RFA for BE. © 2024 American Society for Gastrointestinal Endoscopy
Keywords: adult; clinical article; treatment outcome; aged; aged, 80 and over; middle aged; retrospective studies; histopathology; pathology; retrospective study; feasibility study; feasibility studies; proton pump inhibitor; patient safety; surgery; radiofrequency ablation; esophagus tumor; esophageal neoplasms; rivaroxaban; en bloc resection; adverse event; barrett esophagus; endoscopic mucosal resection; procedures; esophagoscopy; esophagus surgery; endoscopic submucosal dissection; very elderly; humans; human; male; female; article; patient history of therapy
Journal Title: Gastrointestinal Endoscopy
Volume: 100
Issue: 1
ISSN: 0016-5107
Publisher: Mosby Elsevier  
Date Published: 2024-07-01
Start Page: 128
End Page: 131
Language: English
DOI: 10.1016/j.gie.2024.02.002
PUBMED: 38340874
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Schattner
    173 Schattner
  2. Mako Koseki
    10 Koseki
  3. Sayaka Yanagi
    9 Yanagi